Apoptotic index and bcl-2 expression as prognostic factors in colorectal carcinoma

Oncology. 2003;64(4):435-42. doi: 10.1159/000070304.

Abstract

Objectives: To examine programmed cell death in 57 colorectal carcinomas (49 primary tumours and 8 metastases) and determine the prognostic significance of apoptosis in colorectal cancer.

Methods: Apoptotic index (AI) was ascertained by counting apoptotic bodies, using terminal deoxynucleotidyl transferase mediated digoxigenin nick end labelling (Tunel assay) and the expression of bcl-2 was examined immunohistochemically. Statistical analysis was used to test the value of clinical variables, histopathological data, AI and bcl-2 expression in predicting the clinical outcome of these patients and the survival function was calculated using the Kaplan-Meier method.

Results: AI was found to have a significant independent effect on survival (p = 0.0006), with lower values of AI conveying better survival.

Conclusion: In summary, these findings reveal that AI is a useful prognostic factor in colorectal carcinoma.

MeSH terms

  • Adult
  • Aged
  • Apoptosis*
  • Biomarkers, Tumor / analysis*
  • Carcinoma / chemistry*
  • Carcinoma / pathology*
  • Carcinoma / secondary
  • Colorectal Neoplasms / chemistry*
  • Colorectal Neoplasms / pathology*
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • In Situ Nick-End Labeling
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Predictive Value of Tests
  • Prognosis
  • Proto-Oncogene Proteins c-bcl-2 / analysis*
  • Survival Analysis

Substances

  • Biomarkers, Tumor
  • Proto-Oncogene Proteins c-bcl-2